WASHINGTON — In February 2022, Senate Majority Leader Chuck Schumer stood alongside constituents in Buffalo, N.Y., and promised to hold a vote to cap costs for insulin at $35 per month for people with all types of insurance. Two years later, he hasn’t followed through.
Democrats have achieved piecemeal progress in making insulin more affordable for millions of people during President Biden’s more than three years in office, but they’ve yet to do so for everyone. And despite Schumer’s repeated promises to hold a vote on whether to expand cost protections to people with all types of insurance, he hasn’t done it.
Following his February 2022 remarks, Schumer promised again to hold a vote to cap insulin costs the next month. He repeated the call over that summer. He continued to call for a vote in March 2023. He said the legislation was a “high priority” last July. And most recently, he called for a vote in a letter to senators on April 5.